Viewing Study NCT05493566


Ignite Creation Date: 2025-12-24 @ 4:39 PM
Ignite Modification Date: 2026-01-03 @ 6:49 AM
Study NCT ID: NCT05493566
Status: RECRUITING
Last Update Posted: 2025-04-01
First Post: 2022-08-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Low-Dose Interleukin-2 and Pembrolizumab for the Treatment of Stage IV Non-Small Cell Lung Cancer
Sponsor: Emory University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module